Coronavirus Update: Moderna Progesses To Phase II, Russia Approves Homegrown Antiviral
CanSino Has Produced Fuller Data
Moderna maintains its lightning pace, but questions about its Phase III trial design remain.
Moderna maintains its lightning pace, but questions about its Phase III trial design remain.